Felson DT: An update on the pathogenesis and epidemiology of osteoarthritis. Radiol Clin North Am. 2004, 42: 1-9. 10.1016/S0033-8389(03)00161-1.
Article
PubMed
Google Scholar
Felson DT, Lawrence RC, Dieppe PA, Hirsch R, Helmick CG, Jordan JM, Kington RS, Lane NE, Nevitt MC, Zhang Y, Sowers M, McAlindon T, Spector TD, Poole AR, Yanovski SZ, Ateshian G, Sharma L, Buckwalter JA, Brandt KD, Fries JF: Osteoarthritis: new insights. Part 1: the disease and its risk factors. Ann Intern Med. 2000, 133: 635-646.
Article
CAS
PubMed
Google Scholar
Green GA: Understanding NSAIDs: from aspirin to COX-2. Clin Cornerstone. 2001, 3: 50-60. 10.1016/S1098-3597(01)90069-9.
Article
CAS
PubMed
Google Scholar
Hochberg MC, Altman RD, Brandt KD, Clark BM, Dieppe PA, Griffin MR, Moskowitz RW, Schnitzer TJ: Guidelines for the medical management of osteoarthritis. Part II. Osteoarthritis of the knee. American College of Rheumatology. Arthritis Rheum. 1995, 38: 1541-1546. 10.1002/art.1780381104.
Article
CAS
PubMed
Google Scholar
Anonymous: Recommendations for the medical management of osteoarthritis of the hip and knee: 2000 update: American College of Rheumatology Subcommittee on Osteoarthritis Guidelines. Arthritis Rheum. 2000, 43: 1905-1915. 10.1002/1529-0131(200009)43:9<1905::AID-ANR1>3.0.CO;2-P.
Article
Google Scholar
Pendleton A, Arden N, Dougados M, Doherty M, Bannwarth B, Bijlsma JW, Cluzeau F, Cooper C, Dieppe PA, Günther KP, Hauselmann HJ, Herrero-Beaumont G, Kaklamanis PM, Leeb B, Lequesne M, Lohmander S, Mazieres B, Mola EM, Pavelka K, Serni U, Swoboda B, Verbruggen AA, Weseloh G, Zimmermann-Gorska I: EULAR recommendations for the management of osteoarthritis: report of task force standing committee for International Clinical Studies including Therapeutic Trials (ESCISIT). Ann Rheum Dis. 2000, 59: 936-944. 10.1136/ard.59.12.936.
Article
PubMed Central
CAS
PubMed
Google Scholar
Singh G: Recent considerations in nonsteroidal anti-inflammatory drug gastropathy. Am J Med. 1998, 105:
Google Scholar
Griffin MR: Epidemiology of nonsteroidal anti-inflammatory drug associated gastrointestinal injury. Am J Med. 1998, 104:
Google Scholar
Wright JM: Double-edged sword of COX-2 selective NSAIDs. CMAJ. 2002, 167: 1131-1137.
PubMed Central
PubMed
Google Scholar
Singh GB, Atal CK: Pharmacology of an extract of salai guggal ex-Boswellia serrata, a new non-steroidal anti-inflammatory agent. Agents Actions. 1986, 18: 407-412. 10.1007/BF01965005.
Article
CAS
PubMed
Google Scholar
Ethan B, Heather B, Theresa DH, Ivo F, Sadaf H, Jens H, David S, Catherine U: Boswellia: An evidence-based systematic review by the natural standard research collaboration. J Herbal Pharmacother. 2004, 4: 63-83. 10.1300/J157v04n02_07.
Google Scholar
Safayhi H, Mack T, Sabieraj J, Anazodo MI, Subramanian LR, Ammon HPT: Boswellic acids: novel, specific, nonredox inhibitors of 5-lipoxygenase. J Pharmacol Exp Ther. 1992, 26: 1143-1146.
Google Scholar
Sailer ER, Subramanian LR, Rall B, Hoernlein RF, Ammon HPT, Safayhi H: Acetyl-11-keto-β-boswellic acid (AKBA): structure requirements or binding and 5-lipoxygenase inhibitory activity. Br J Pharmacol. 1996, 117: 615-618.
Article
PubMed Central
CAS
PubMed
Google Scholar
Roy S, Khanna S, Shah H, Rink C, Phillips C, Preuss H, Subbaraju GV, Trimurtulu G, Krishnaraju AV, Bagchi M, Bagchi D, Sen CK: Human genome screen to identify the genetic basis of the anti-inflammatory effects of Boswellia in microvascular endothelial cells. DNA Cell Biol. 2005, 24: 244-255. 10.1089/dna.2005.24.244.
Article
CAS
PubMed
Google Scholar
Lalithakumari K, Krishnaraju AV, Sengupta K, Subbaraju GV, Chatterjee A: Safety and toxicological evaluation of a novel, standardized 3-O-acetyl-11-keto-β-boswellic acid (AKBA)-enriched Boswellia serrata extract (5-Loxin). Toxicol Mechanisms Methods. 2006, 16: 199-226. 10.1080/15376520600620232.
Article
CAS
Google Scholar
Joos S, Rosemann T, Szecsenyi J, Hahn EG, Willich SN, Brinkhaus B: Use of complementary and alternative medicine in Germany – a survey of patients with inflammatory bowel disease. BMC Complement Altern Med. 2006, 6: 19-10.1186/1472-6882-6-19.
Article
PubMed Central
PubMed
Google Scholar
Anthoni C, Laukoetter MG, Rijcken E, Vowinkel T, Mennigen R, Muller S, Senninger N, Russell J, Jauch J, Bergmann J, Granger DN, Krieglstein CF: Mechanisms underlying the anti-inflammatory actions of boswellic acid derivatives in experimental colitis. Am J Physiol Gastrointest Liver Physiol. 2006, 290: G1131-G1137. 10.1152/ajpgi.00562.2005.
Article
CAS
PubMed
Google Scholar
Gupta I, Parihar A, Malhotra P, Gupta S, Ludtke R, Safayhi H, Ammon HP: Effects of gum resin of Boswellia serrata in patients with chronic colitis. Planta Med. 2001, 67: 391-395. 10.1055/s-2001-15802.
Article
CAS
PubMed
Google Scholar
Kimmatkar N, Thawani V, Hingorani L, Khiyani R: Efficacy and tolerability of Boswellia serrata extract in treatment of osteoarthritis of knee: a randomized double blind placebo controlled trial. Phytomedicine. 2003, 10: 3-7. 10.1078/094471103321648593.
Article
CAS
PubMed
Google Scholar
Bellamy N, Buchnan WW, Goldsmith CH, Campbell J, Stitt LW: Validation study of WOMAC: a health status instrument for measuring clinically important patient relevant outcomes to anti-rheumatic drug therapy in patients with osteoarthritis of the hip or knee. J Rheumatol. 1988, 15: 1833-1840.
CAS
PubMed
Google Scholar
Lequesne MG, Mery C, Samson M, Gerard P: Indexes of severity for osteoarthritis of the hip and knee validation-value in comparison with other assessment tests. Scand J Rheumatology. 1987, 65: 85-89. 10.3109/03009748709102182.
Article
CAS
Google Scholar
Chapman CR, Casey KL, Dubner R, Foley KM, Gracely RH, Reading AE: Pain measurement: an overview. Pain. 1985, 22: 1-31. 10.1016/0304-3959(85)90145-9.
Article
CAS
PubMed
Google Scholar
Bellamy N, Bell MJ, Goldsmith CH, Pericak D, Walker V, Raynauld JP, Torrance GW, Tugwell P, Polisson R: The effectiveness of hylan G-F 20 in patients with knee osteoarthritis: an application of two sets of response criteria developed by the OARSI and one set developed by OMERACT-OARSI. Osteoarthritis Cartilage. 2005, 13: 104-110. 10.1016/j.joca.2004.10.016.
Article
PubMed
Google Scholar
Day R, Morrison B, Luza A, Castaneda O, Strusberg A, Nahir M, Helgetveit KB, Kress B, Daniels B, Bolognese J, Krupa D, Seidenberg B, Ehrich E: A randomized trial of the efficacy and tolerability of the COX-2 inhibitor rofecoxib vs ibuprofen in patients with osteoarthritis. Arch Intern Med. 2000, 160: 1781-1787. 10.1001/archinte.160.12.1781.
Article
CAS
PubMed
Google Scholar
Gottesdiener K, Schnitzer T, Fisher C, Bockow B, Markenson J, Ko A, DeTora L, Curtis S, Geissler L, Gertz BJ: Results of a randomized, dose-ranging trial of etoricoxib in patients with osteoarthritis. Rheumatology (Oxford). 2002, 41: 1052-1061. 10.1093/rheumatology/41.9.1052.
Article
CAS
Google Scholar
Bingham CO, Sebba AI, Rubin BR, Ruoff GE, Kremer J, Bird S, Smugar SS, Fitzgerald BJ, O'Brien K, Tershakovec AM: Efficacy and safety of etoricoxib 30 mg and celecoxib 200 mg in the treatment of osteoarthritis in two identically designed, randomized, placebo-controlled, non-inferiority studies. Rheumatology (Oxford). 2007, 46: 496-507. 10.1093/rheumatology/kel296.
Article
CAS
Google Scholar
Reginster JY, Malmstrom K, Mehta A, Bergman G, Ko AT, Curtis SP, Reicin AS: Evaluation of the efficacy and safety of etoricoxib compared with naproxen in two, 138-week randomized studies of osteoarthritis patients. Ann Rheum Dis. 2007, 66: 945-951. 10.1136/ard.2006.059162.
Article
PubMed Central
CAS
PubMed
Google Scholar
Power analysis for ANOVA designs. [http://www.math.yorku.cal/SCS/Online/power/]
Garnero P, Rousseau J, Delmas PD: Molecular basis and clinical use of biochemical markers of bone, cartilage and synovium in joint diseases. Arthritis Rheum. 2000, 43: 953-968. 10.1002/1529-0131(200005)43:5<953::AID-ANR1>3.0.CO;2-Q.
Article
CAS
PubMed
Google Scholar
Felson DT: Osteoarthritis of the knee. N Engl J Med. 2006, 354: 841-848. 10.1056/NEJMcp051726.
Article
CAS
PubMed
Google Scholar
Turner JA, Deyo RA, Loeser JD, Von Korff M, Fordyce WE: The importance of placebo effects in pain treatment and research. JAMA. 1994, 271: 1609-1614. 10.1001/jama.271.20.1609.
Article
CAS
PubMed
Google Scholar
Walach H, Sadaghiani C, Dehm C, Bierman D: The therapeutic effect of clinical trials: understanding placebo response rates in clinical trials: a secondary analysis. BMC Med Res Methodol. 2005, 5: 26-37. 10.1186/1471-2288-5-26.
Article
PubMed Central
PubMed
Google Scholar
McAlindon TE, LaValley MP, Gulin JP, Felson DT: Glucosamine and chondroitin for treatment of osteoarthritis: a systematic quality assessment and meta-analysis. JAMA. 2000, 283: 1469-1475. 10.1001/jama.283.11.1469.
Article
CAS
PubMed
Google Scholar
Zenk JL, Helmer TR, Kuskowski MA: The effects of milk protein concentrate on the symptoms of osteoarthritis in adults: an exploratory, randomized, double blind, placebo-controlled trial. Curr Ther Res. 2002, 63: 430-442. 10.1016/S0011-393X(02)80049-2.
Article
CAS
Google Scholar
Caterson B, Flannery CR, Hughes CE, Little CB: Mechanisms involved in cartilage proteoglycan catabolism. Matrix Biol. 2000, 19: 333-344. 10.1016/S0945-053X(00)00078-0.
Article
CAS
PubMed
Google Scholar
Little CB, Hughes CE, Curtis CL, Janusz MJ, Bohne R, Wang-Weigand S, Taiwo YO, Mitchell PG, Otterness IG, Flannery CR, Caterson B: Matrix metalloproteinases are involved in C-terminal and interglobular domain processing of cartilage aggrecan in late stage cartilage degradation. Matrix Biol. 2002, 21: 271-288. 10.1016/S0945-053X(02)00004-5.
Article
CAS
PubMed
Google Scholar